Abbott Laboratories
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $5.75B | $4.88B | $3.61B |
| Depreciation & Amortization | — | — | — |
| Depreciation | $1.21B | $1.05B | $1.07B |
| Amortization | $878.5M | $787.1M | $782.0M |
| Stock-Based Compensation | $366.4M | $347.0M | $429.7M |
| Net Cash from Operating Activities | $7.28B | $6.99B | $5.18B |
| Investing Activities | |||
| Capital Expenditures | $1.09B | $1.29B | $1.66B |
| Business Acquisitions | $2.37B | $250.0M | — |
| Net Cash from Investing Activities | $-3.70B | $-2.09B | — |
| Financing Activities | |||
| Dividends Paid | $2.41B | $2.17B | $1.96B |
| Stock Repurchases | $826.3M | $1.08B | $1.06B |
| Net Cash from Financing Activities | $1.00B | $-3.49B | — |
| Net Change in Cash | $4.70B | $1.66B | $1.94B |
| Free Cash Flow | $6.19B | $5.71B | $3.53B |